3 篇文章 · 精选中国旅行贴士
China vs Thailand, Malaysia, Vietnam & Indonesia. Standard procedures: SEA is cheaper. Complex oncology & cardiac: China wins on availability and price. CAR-T & proton therapy available in China but not in most SEA countries.
China vs Thailand healthcare deep dive: Thailand leads with 3M patients/yr, 62+ JCI hospitals, excellent English, mature infrastructure. China wins on advanced oncology (proton therapy, CAR-T), diagnostics value ($70 MRI), complex surgery volumes (15,000+ cardiac surgeries/yr), TCM integration. Country-by-country patient recommendations.
Thailand dominates medical tourism with a 25.5% share of the APAC market. China is the rising challenger with superior cancer treatment and technology. Here's how to choose between them in 2026.
